{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T07:23:03Z","timestamp":1791098583384,"version":"4.1.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["M\u00e9decine et Maladies Infectieuses"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.medmal.2006.12.006","type":"journal-article","created":{"date-parts":[[2007,3,2]],"date-time":"2007-03-02T12:46:45Z","timestamp":1172839605000},"page":"253-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Les effets ind\u00e9sirables des\u00a0antituberculeux : \u00e9pid\u00e9miologie, m\u00e9canismes et\u00a0conduite \u00e0\u00a0tenir"],"prefix":"10.1016","volume":"37","author":[{"given":"K.","family":"Aouam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Chaabane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Loussa\u00efef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Ben Romdhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.-A.","family":"Boughattas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Chakroun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.medmal.2006.12.006_bib1","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1164\/rccm.200206-626OC","article-title":"Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis","volume":"167","author":"Yee","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"4","key":"10.1016\/j.medmal.2006.12.006_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1164\/rccm.167.4.603","article-title":"American Thoracic Society\/Centers for Disease Control and Prevention\/Infectious Diseases Society of America: treatment of tuberculosis","volume":"167","author":"Blumberg","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"2","key":"10.1016\/j.medmal.2006.12.006_bib3","first-page":"112","article-title":"Troubles du comportement apr\u00e8s prise d\u2019isoniazide","volume":"94","author":"Djibo","year":"2001","journal-title":"Bull. Soc. Pathol. Exot."},{"key":"10.1016\/j.medmal.2006.12.006_bib4","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1542\/peds.95.5.700","article-title":"Acute isoniazid neurotoxicity in an urban hospital","volume":"95","author":"Binita","year":"1995","journal-title":"Pediatrics"},{"key":"10.1016\/j.medmal.2006.12.006_bib5","first-page":"35","article-title":"M\u00e9dicaments antituberculeux: effets secondaires et conduite \u00e0 tenir","volume":"67","author":"El Ftouh","year":"1998","journal-title":"Med. Maghreb"},{"issue":"6","key":"10.1016\/j.medmal.2006.12.006_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1176\/appi.psy.45.6.537","article-title":"Confusion associated with isoniazid-induced pyridoxine deficiency","volume":"45","author":"Reeves","year":"2004","journal-title":"Psychosomatics"},{"issue":"3","key":"10.1016\/j.medmal.2006.12.006_bib7","first-page":"183","article-title":"Neuropathies optiques toxiques graves induites par l\u2019isoniazide","volume":"18","author":"Boulanouar","year":"1995","journal-title":"J. Fr. Ophtalmol."},{"key":"10.1016\/j.medmal.2006.12.006_bib8","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/BF01711541","article-title":"Isoniazid overdose: four case reports and review of the literature","volume":"21","author":"Alvarez","year":"1995","journal-title":"Intensive Care Med."},{"issue":"2","key":"10.1016\/j.medmal.2006.12.006_bib9","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1176\/jnp.17.2.256","article-title":"Persisting dementia after isoniazid overdose","volume":"17","author":"Mc Lay","year":"2005","journal-title":"J. Neuropsychiatr. Clin. Neurosci."},{"key":"10.1016\/j.medmal.2006.12.006_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0041-3879(89)90033-0","article-title":"Isoniazid-related hepatotoxicity: a study of the effect of rifampicin administration on the metabolism of acetylisoniazid in man","volume":"70","author":"Jenner","year":"1989","journal-title":"Tubercle"},{"issue":"4","key":"10.1016\/j.medmal.2006.12.006_bib11","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1183\/09031936.04.00053804","article-title":"G-CSF enables completion of tuberculosis therapy associated with iatrogenic neutropenia","volume":"23","author":"Cormican","year":"2004","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.medmal.2006.12.006_bib12","first-page":"660","article-title":"Isoniazid induced pellagra and the n acetyltransferase gene genotype","volume":"56","author":"Tatsuyuki","year":"1999","journal-title":"Am. J. Psychiatr."},{"issue":"6","key":"10.1016\/j.medmal.2006.12.006_bib13","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1345\/aph.1D525","article-title":"Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors","volume":"38","author":"Shakya","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.medmal.2006.12.006_bib14","first-page":"906","article-title":"H\u00e9patites m\u00e9dicamenteuses: diagnostic et prise en charge","volume":"23","author":"Mallat","year":"1999","journal-title":"Gastroenterol. Clin. Biol."},{"issue":"11","key":"10.1016\/j.medmal.2006.12.006_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.281.11.1014","article-title":"Hepatotoxicity associated with isoniazid preventive therapy","volume":"281","author":"Nolan","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.medmal.2006.12.006_bib16","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1136\/thx.51.2.132","article-title":"Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study","volume":"51","author":"Pande","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.medmal.2006.12.006_bib17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1034\/j.1398-9995.2002.23832_9.x","article-title":"Adverse reactions to pyrazinamide","volume":"57","author":"Ribi","year":"2002","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.medmal.2006.12.006_bib18","first-page":"341","article-title":"Leukopenia due to antituberculous chemotherapy including rifampicin and isoniazid","volume":"79","author":"Nagayama","year":"2004","journal-title":"Kekkaku"},{"issue":"5","key":"10.1016\/j.medmal.2006.12.006_bib19","first-page":"545","article-title":"Isoniazid-induced anaphylaxis","volume":"43","author":"Crook","year":"2003","journal-title":"J. Clin. Pharmacol."},{"issue":"8","key":"10.1016\/j.medmal.2006.12.006_bib20","first-page":"632","article-title":"Isoniazid-induced fever","volume":"95","author":"Lee","year":"1996","journal-title":"J. Formos. Med. Assoc."},{"issue":"4","key":"10.1016\/j.medmal.2006.12.006_bib21","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1378\/chest.91.4.620","article-title":"Severe febrile reaction to isoniazid","volume":"91","author":"Gabrail","year":"1987","journal-title":"Chest"},{"issue":"10","key":"10.1016\/j.medmal.2006.12.006_bib22","first-page":"741","article-title":"Spiking fever induced by isoniazid","volume":"17","author":"Henderson","year":"1983","journal-title":"Drug Intell. Clin. Pharm."},{"issue":"2","key":"10.1016\/j.medmal.2006.12.006_bib23","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1378\/chest.75.2.196","article-title":"Isoniazid-induced fever","volume":"75","author":"Dasta","year":"1979","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.medmal.2006.12.006_bib24","first-page":"101","article-title":"Drug fever due to isoniazid","volume":"13","author":"Akalin","year":"1979","journal-title":"Mikrobiyol. Bul."},{"key":"10.1016\/j.medmal.2006.12.006_bib25","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1034\/j.1398-9995.1999.00161.x","article-title":"Hypersensitivity syndrome from isoniazid","volume":"54","author":"Rubira","year":"1999","journal-title":"Allergy"},{"issue":"2","key":"10.1016\/j.medmal.2006.12.006_bib26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.jaci.2004.01.607","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) secondary to anti-tuberculosis therapy with features of isoniazid toxicity","volume":"113","author":"Ditto","year":"2004","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.medmal.2006.12.006_bib27","first-page":"172","article-title":"Recurrent acute pancreatitis after isoniazid","volume":"62","author":"Chow","year":"2004","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.medmal.2006.12.006_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.meegid.2003.01.001","article-title":"Antituberculosis drugs and hepatotoxicity","volume":"4","author":"Sharma","year":"2004","journal-title":"Infect. Genet. Evol."},{"issue":"26","key":"10.1016\/j.medmal.2006.12.006_bib29","first-page":"1212","article-title":"Toxicit\u00e9 h\u00e9patique des antituberculeux: r\u00f4le des diff\u00e9rents m\u00e9dicaments: 199 observations","volume":"22","author":"Altam","year":"1993","journal-title":"Presse Med."},{"issue":"6","key":"10.1016\/j.medmal.2006.12.006_bib30","first-page":"376","article-title":"A case of rifampicin associated pseudomembranous colitis","volume":"43","author":"Kim","year":"2004","journal-title":"Korean J. Gastroenterol."},{"issue":"8932","key":"10.1016\/j.medmal.2006.12.006_bib31","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0140-6736(94)90782-X","article-title":"Eosinophilic colitis due to rifampicin","volume":"344","author":"Lange","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2006.12.006_bib32","first-page":"1167","article-title":"Manifestations d\u2019hypersensibilit\u00e9 \u00e0 la rifampicine","volume":"32","author":"Fenniche","year":"2003","journal-title":"Presse Med."},{"key":"10.1016\/j.medmal.2006.12.006_bib33","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/00005792-199911000-00001","article-title":"Hypersensitivity reactions to rifampicin. Pathogenic mechanisms, clinical manifestations, management strategies, and review of the anaphylactic-like reactions","volume":"78","author":"Martinez","year":"1999","journal-title":"Medicine"},{"key":"10.1016\/j.medmal.2006.12.006_bib34","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1136\/thorax.57.11.1000","article-title":"Pneumonitis induced by rifampicin","volume":"7","author":"Kunichika","year":"2002","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.medmal.2006.12.006_bib35","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1053\/ajkd.2002.35675","article-title":"Acute renal failure due to rifampicin: a study of 25 patients","volume":"40","author":"Thangamani","year":"2002","journal-title":"Am. J. Kidneys Dis."},{"issue":"1","key":"10.1016\/j.medmal.2006.12.006_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1053\/ajkd.1998.v31.pm9428460","article-title":"Rifampicin associated acute renal failure: pathophysiologic, immunologic, and clinical features","volume":"31","author":"De Vierse","year":"1998","journal-title":"Am. J. Kidneys Dis."},{"key":"10.1016\/j.medmal.2006.12.006_bib37","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/ndt\/13.4.924","article-title":"Rifampicin induced acute renal failure: a series of 60 patients","volume":"13","author":"Covic","year":"1998","journal-title":"Nephrol. Dial. Transplant."},{"issue":"37","key":"10.1016\/j.medmal.2006.12.006_bib38","first-page":"2037","article-title":"Accident immunoallergique grave chez un patient trait\u00e9 quotidiennement depuis deux mois par rifampicine","volume":"28","author":"Fardet","year":"1999","journal-title":"Presse Med."},{"key":"10.1016\/j.medmal.2006.12.006_bib39","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1093\/ndt\/16.1.190-a","article-title":"Continuous rifampicin administration inducing acute renal failure","volume":"16","author":"Bassilios","year":"2001","journal-title":"Nephrol. Dial. Transplant."},{"issue":"9","key":"10.1016\/j.medmal.2006.12.006_bib40","first-page":"185","article-title":"Updated guidelines for the use of rifabutin or rifampin for the treatment and prevention of tuberculosis among HIV-infected patients taking protease inhibitors or nonnucleoside reverse transcriptase inhibitors","volume":"49","year":"2000","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.medmal.2006.12.006_bib41","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/380794","article-title":"Pharmacokinetics interaction between rifampin and combination of indinavir and low dose ritonavir in HIV-infected patients","volume":"38","author":"Justensen","year":"2004","journal-title":"Clin. Infect. Dis."},{"issue":"11","key":"10.1016\/j.medmal.2006.12.006_bib42","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2165\/00003088-200443110-00003","article-title":"Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS","volume":"43","author":"Panomvana","year":"2004","journal-title":"Clin. Pharmacokinet."},{"issue":"9","key":"10.1016\/j.medmal.2006.12.006_bib43","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2165\/00003088-200342090-00003","article-title":"Pharmacokinetic interactions with rifampicin: clinical relevance","volume":"42","author":"Niemi","year":"2003","journal-title":"Clin. Pharmacokinet."},{"issue":"3","key":"10.1016\/j.medmal.2006.12.006_bib44","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1378\/chest.123.3.967","article-title":"Fatal liver injury associated with rifampin-pyrazinamide treatment of latent tuberculosis infection","volume":"23","author":"Castro","year":"2003","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.medmal.2006.12.006_bib45","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00004836-199706000-00019","article-title":"Pyrazinamide-induced granulomatous hepatitis","volume":"24","author":"Knobel","year":"1997","journal-title":"J. Clin. Gastroenterol."},{"issue":"2","key":"10.1016\/j.medmal.2006.12.006_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.7144\/sgf.5.115","article-title":"Hyperuricemia and arthralgia during pyrazinamide treatment","volume":"37","author":"Inoue","year":"1999","journal-title":"Nihon Kokyuki Gakkai Zasshi"},{"issue":"3","key":"10.1016\/j.medmal.2006.12.006_bib47","first-page":"136","article-title":"Pyrazinamide induced hyperuricemia in patients taking antituberculous therapy","volume":"14","author":"Solangi","year":"2004","journal-title":"J. Coll. Physicians Surg. Pak."},{"issue":"5","key":"10.1016\/j.medmal.2006.12.006_bib48","doi-asserted-by":"crossref","first-page":"701","DOI":"10.4065\/79.5.701","article-title":"Ocular ethambutol toxicity","volume":"79","author":"Herchline","year":"2004","journal-title":"Mayo Clin. Proc."},{"issue":"7","key":"10.1016\/j.medmal.2006.12.006_bib49","first-page":"300","article-title":"Rapidly developing optic neuritis secondary to ethambutol: possible mechanism of injury","volume":"55","author":"Ali","year":"2005","journal-title":"J. Pak Med. Assoc."},{"key":"10.1016\/j.medmal.2006.12.006_bib50","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1136\/bjo.2004.058099","article-title":"Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy","volume":"89","author":"Lai","year":"2005","journal-title":"Br. J. Ophthalmol."},{"key":"10.1016\/j.medmal.2006.12.006_bib51","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2165\/00003088-199936020-00001","article-title":"Once daily aminoglycoside therapy: is it less toxic than multiple daily doses and how should it be monitored","volume":"36","author":"Barclary","year":"1999","journal-title":"Clin. Pharmacokinet."},{"issue":"1077","key":"10.1016\/j.medmal.2006.12.006_bib52","first-page":"428","article-title":"Ocular toxicity from ethambutol: a review of four cases and recommended precautions","volume":"111","author":"Sivakumaran","year":"1998","journal-title":"N. Z. Med. J."},{"issue":"1","key":"10.1016\/j.medmal.2006.12.006_bib53","first-page":"56","article-title":"Ocular toxicity of ethambutol","volume":"12","author":"Chan","year":"2006","journal-title":"Hong Kong Med. J."},{"issue":"4","key":"10.1016\/j.medmal.2006.12.006_bib54","first-page":"230","article-title":"Evaluation of visual functions in patients on ethambutol therapy for tuberculosis: a prospective study","volume":"35","author":"Goyal","year":"2003","journal-title":"J. Commun. Dis."},{"key":"10.1016\/j.medmal.2006.12.006_bib55","first-page":"190","article-title":"Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway","volume":"40","author":"Heng","year":"1999","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.medmal.2006.12.006_bib56","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1468-1331.2005.01025.x","article-title":"Ocular complications of neurological therapy","volume":"12","author":"Hadjikoutisa","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.medmal.2006.12.006_bib57","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1159\/000186675","article-title":"Acute interstitial nephritis induced by ethambutol","volume":"59","author":"Garcia","year":"1991","journal-title":"Nephron"},{"key":"10.1016\/j.medmal.2006.12.006_bib58","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1136\/bmj.2.6044.1105-a","article-title":"Two cases of ethambutol nephrotoxicity","volume":"2","author":"Collier","year":"1976","journal-title":"BMJ"},{"key":"10.1016\/j.medmal.2006.12.006_bib59","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1093\/ndt\/gfh166","article-title":"Ethambutol-induced acute renal failure","volume":"19","author":"Soon","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"issue":"5","key":"10.1016\/j.medmal.2006.12.006_bib60","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1378\/chest.106.5.1638","article-title":"Ethambutol-induced neutropenia and eosinophilia","volume":"106","author":"Wong","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.medmal.2006.12.006_bib61","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1183\/09031936.95.08050866","article-title":"Ethambutol-induced pulmonary infiltrates with eosinophilia and skin involvement","volume":"8","author":"Wong","year":"1995","journal-title":"Eur. Respir. J."},{"issue":"4","key":"10.1016\/j.medmal.2006.12.006_bib62","first-page":"332","article-title":"Amynoglycoside-induced hearing loss","volume":"60","author":"Yamasoba","year":"2002","journal-title":"Nippon Rinsho"},{"key":"10.1016\/j.medmal.2006.12.006_bib63","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1086\/420742","article-title":"Aminoglycoside toxicity: daily versus thrice-weekly dosing for treatment of mycobacterial diseases","volume":"38","author":"Peloquin","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.medmal.2006.12.006_bib64","series-title":"Pharmacologie clinique. Bases de la th\u00e9rapeutique. 2e \u00e9dition","author":"Giroud","year":"1988"},{"key":"10.1016\/j.medmal.2006.12.006_bib65","series-title":"M\u00e9dicaments anti-infectieux","author":"Carbon","year":"1995"},{"issue":"1","key":"10.1016\/j.medmal.2006.12.006_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1345\/aph.1E430","article-title":"A rare case of streptomycin-induced toxic epidermal necrolysis in a patient with tuberculosis: a therapeutic dilemma","volume":"39","author":"Hmouda","year":"2005","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.medmal.2006.12.006_bib67","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0140-6736(95)90468-9","article-title":"Antituberculosis therapy and acute liver failure","volume":"345","author":"Mitchell","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.medmal.2006.12.006_bib68","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1136\/thx.53.7.536","article-title":"Chemotherapy and management of tuberculosisin the United Kingdom: recommendations 1998","volume":"53","year":"1998","journal-title":"Thorax"},{"key":"10.1016\/j.medmal.2006.12.006_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00002018-199512010-00001","article-title":"Ovoidance and management of adverse reactions to antituberculosis drugs","volume":"12","author":"Patel","year":"1995","journal-title":"Drug Saf."},{"key":"10.1016\/j.medmal.2006.12.006_bib70","first-page":"88","article-title":"Accoutumance orale rapide \u00e0 la rifampicine en suspension","volume":"45","author":"Ben M\u2019rad","year":"2005","journal-title":"Rev. Fr. Allergol. Immunol. Clin."},{"issue":"12","key":"10.1016\/j.medmal.2006.12.006_bib71","first-page":"699","article-title":"Desensitization therapy for allergic reactions of antituberculous drugs-evaluation of desensitization therapy according to the guidelines of the Japanese Society for Tuberculosis","volume":"75","author":"Kobashi","year":"2000","journal-title":"Kekkaku"},{"issue":"2","key":"10.1016\/j.medmal.2006.12.006_bib72","first-page":"104","article-title":"Oral desensitization to antitubercular agents","volume":"53","author":"Drira","year":"1997","journal-title":"Rev. Pneumol. Clin."}],"container-title":["M\u00e9decine et Maladies Infectieuses"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X07000273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0399077X07000273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T01:01:58Z","timestamp":1759971718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0399077X07000273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":72,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0399077X07000273"],"URL":"https:\/\/doi.org\/10.1016\/j.medmal.2006.12.006","relation":{},"ISSN":["0399-077X"],"issn-type":[{"value":"0399-077X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Les effets ind\u00e9sirables des\u00a0antituberculeux: \u00e9pid\u00e9miologie, m\u00e9canismes et\u00a0conduite \u00e0\u00a0tenir","name":"articletitle","label":"Article Title"},{"value":"M\u00e9decine et Maladies Infectieuses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medmal.2006.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}